Načítá se...
A consensus statement regarding the utilization of BMP in spine surgery
Recombinant human bone morphogenetic protein - 2 (rh-BMP-2) was first approved by the United States Food and Drug Administration (FDA) in 2002 for use in anterior lumbar interbody fusions. Since that time, it has been estimated that “off label” use accounts for 85 % of applications. Original, indust...
Uloženo v:
| Vydáno v: | Curr Rev Musculoskelet Med |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer US
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4596161/ https://ncbi.nlm.nih.gov/pubmed/24947400 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12178-014-9224-0 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|